Structures by: Wang B.
Total: 904
C8H12Mo8N4O26,4(C4H6N2),4(C4H7N2)
C8H12Mo8N4O26,4(C4H6N2),4(C4H7N2)
CrystEngComm (2013) 15, 37 7410
a=17.379(3)Å b=10.932(2)Å c=24.384(4)Å
α=90.00° β=134.332(8)° γ=90.00°
C10H16Mo8N4O26,4(C5H9N2)
C10H16Mo8N4O26,4(C5H9N2)
CrystEngComm (2013) 15, 37 7410
a=11.3366(13)Å b=11.3529(13)Å c=11.3639(14)Å
α=72.391(2)° β=71.058(2)° γ=80.060(2)°
C12H18MoN6O3
C12H18MoN6O3
CrystEngComm (2013) 15, 37 7410
a=11.6102(9)Å b=11.6102(9)Å c=19.4306(14)Å
α=90.00° β=90.00° γ=120.00°
C30H36Mo3N12O9
C30H36Mo3N12O9
CrystEngComm (2013) 15, 37 7410
a=9.6874(7)Å b=18.8238(14)Å c=10.3652(6)Å
α=90.00° β=102.994(7)° γ=90.00°
C12H20Mo8N4O26,4(C6H11N2),2(C6H10N2),2(H2O)
C12H20Mo8N4O26,4(C6H11N2),2(C6H10N2),2(H2O)
CrystEngComm (2013) 15, 37 7410
a=12.5903(18)Å b=11.8542(16)Å c=24.806(3)Å
α=90.00° β=100.449(2)° γ=90.00°
C64H96Mo9N32O32S3
C64H96Mo9N32O32S3
CrystEngComm (2013) 15, 37 7410
a=15.878(3)Å b=10.1503(19)Å c=16.704(3)Å
α=90.00° β=115.779(3)° γ=90.00°
C12H20Mo8N4O26,4(C6H11N2)
C12H20Mo8N4O26,4(C6H11N2)
CrystEngComm (2013) 15, 37 7410
a=10.1921(4)Å b=21.5036(9)Å c=15.3277(5)Å
α=90.00° β=120.334(2)° γ=90.00°
CGCScCl
C42H62Cl2N2O2Sc2Si2,2(C7H8)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 38 14215-14218
a=8.7632(13)Å b=12.0184(17)Å c=13.1920(19)Å
α=84.425(6)° β=82.784(6)° γ=83.648(6)°
ScBorylLiCl
C58H86BClLiN3O3ScSi
Dalton transactions (Cambridge, England : 2003) (2014) 43, 38 14215-14218
a=13.004(3)Å b=23.237(5)Å c=19.598(4)Å
α=90.00° β=100.167(5)° γ=90.00°
CGCScNCNB
C50H76BN5ScSi
Dalton transactions (Cambridge, England : 2003) (2014) 43, 38 14215-14218
a=10.621(4)Å b=13.697(4)Å c=17.546(6)Å
α=95.341(8)° β=93.924(7)° γ=107.176(7)°
CGCSc2NO
C47H67BN5O3ScSi
Dalton transactions (Cambridge, England : 2003) (2014) 43, 38 14215-14218
a=12.343(5)Å b=25.971(11)Å c=14.894(6)Å
α=90.00° β=95.775(8)° γ=90.00°
C43H59BClN3ScSi1,C12H30O6Li1,C4H10O2,C6H6
C43H59BClN3ScSi1,C12H30O6Li1,C4H10O2,C6H6
Dalton transactions (Cambridge, England : 2003) (2014) 43, 38 14215-14218
a=12.3886(14)Å b=17.623(2)Å c=17.974(2)Å
α=66.157(2)° β=85.712(2)° γ=76.132(2)°
C60H50N2O2Zr
C60H50N2O2Zr
Dalton transactions (Cambridge, England : 2003) (2016) 45, 25 10308-10318
a=11.2590(10)Å b=24.229(2)Å c=17.8544(15)Å
α=90.00° β=91.370(2)° γ=90.00°
C62H54N2O2Zr
C62H54N2O2Zr
Dalton transactions (Cambridge, England : 2003) (2016) 45, 25 10308-10318
a=22.6289(19)Å b=15.0048(13)Å c=18.0332(16)Å
α=90.00° β=101.611(2)° γ=90.00°
C60H50HfN2O2
C60H50HfN2O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 25 10308-10318
a=17.8992(11)Å b=19.3310(12)Å c=20.5734(13)Å
α=97.5330(10)° β=94.4190(10)° γ=116.1370(10)°
C48H96N16S8Cu10,6(BF4),2.25(C2H3N)
C48H96N16S8Cu10,6(BF4),2.25(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 7 2997-3002
a=14.014(3)Å b=31.074(6)Å c=21.818(4)Å
α=90° β=90.39(3)° γ=90°
C32H30Cl2N2O5Ru2
C32H30Cl2N2O5Ru2
Dalton Transactions (2009) 35 7230-7235
a=9.0789(5)Å b=14.6352(7)Å c=23.5139(13)Å
α=90.00° β=91.894(3)° γ=90.00°
C28.25H31.5BrCl2.5N2ORu
C28.25H31.5BrCl2.5N2ORu
Dalton Transactions (2009) 35 7230-7235
a=11.291(3)Å b=27.990(7)Å c=18.336(4)Å
α=90.00° β=96.283(2)° γ=90.00°
C34H28N2O8Ru3
C34H28N2O8Ru3
Dalton Transactions (2009) 35 7230-7235
a=14.419(3)Å b=15.676(3)Å c=16.866(3)Å
α=91.674(2)° β=98.914(3)° γ=116.114(3)°
C33H35N3OPd
C33H35N3OPd
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17177-17183
a=15.043(4)Å b=9.959(3)Å c=18.770(5)Å
α=90.00° β=94.820(4)° γ=90.00°
C34H46N3OPd
C34H46N3OPd
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17177-17183
a=10.217(2)Å b=16.494(3)Å c=18.475(4)Å
α=101.68(3)° β=90.47(3)° γ=91.58(3)°
C30.63H37.5N3OPd
C30.63H37.5N3OPd
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 17177-17183
a=16.518(3)Å b=13.500(3)Å c=26.535(5)Å
α=90.00° β=101.11(3)° γ=90.00°
C42H22F6FeN10S2
C42H22F6FeN10S2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 8938-8941
a=12.8112(5)Å b=10.0738(4)Å c=29.6623(11)Å
α=90.00° β=90.00° γ=90.00°
C42H22F6FeN10S2
C42H22F6FeN10S2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 8938-8941
a=12.8042(6)Å b=10.6288(6)Å c=28.3592(14)Å
α=90.00° β=90.00° γ=90.00°
C42H22F6FeN10S2
C42H22F6FeN10S2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 8938-8941
a=12.8371(6)Å b=10.6474(5)Å c=28.4181(13)Å
α=90.00° β=90.00° γ=90.00°
C42H22F6FeN10S2
C42H22F6FeN10S2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 8938-8941
a=12.9544(8)Å b=10.7221(8)Å c=28.685(2)Å
α=90.00° β=90.00° γ=90.00°
C14H22O11Tb2,H2O
C14H22O11Tb2,H2O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 12 5276-5279
a=7.1577(5)Å b=9.9319(10)Å c=14.9339(17)Å
α=71.781(10)° β=82.756(8)° γ=75.432(8)°
C14H22Dy2O11,H2O
C14H22Dy2O11,H2O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 12 5276-5279
a=7.1628(5)Å b=9.9371(6)Å c=14.9972(10)Å
α=71.520(6)° β=83.425(6)° γ=75.425(6)°
C48H42N2O2Zr
C48H42N2O2Zr
Dalton transactions (Cambridge, England : 2003) (2016) 45, 25 10308-10318
a=15.1215(11)Å b=9.6375(7)Å c=26.4463(18)Å
α=90.00° β=97.815(2)° γ=90.00°
C47H56BCoFeS3
C47H56BCoFeS3
Catalysis Science & Technology (2019) 9, 22 6492
a=20.576(2)Å b=16.9755(19)Å c=12.0227(14)Å
α=90° β=90° γ=90°
C16H22B2N2O3
C16H22B2N2O3
Chemical Science (2019)
a=7.0474(3)Å b=10.6520(4)Å c=22.2574(9)Å
α=90° β=90.2535(8)° γ=90°
C21H20B2N4O2
C21H20B2N4O2
Nature Communications (2016) 7, 11871
a=15.071(5)Å b=8.378(3)Å c=14.966(5)Å
α=90° β=90° γ=90°
C22H23B2F3N4O3S
C22H23B2F3N4O3S
Nature Communications (2016) 7, 11871
a=7.2251(7)Å b=14.5333(12)Å c=22.5468(19)Å
α=90° β=91.921(5)° γ=90°
C31H32B2ClN5O
C31H32B2ClN5O
Nature Communications (2016) 7, 11871
a=7.5717(11)Å b=13.808(2)Å c=27.350(4)Å
α=90° β=96.647(5)° γ=90°
C21H19NO
C21H19NO
Organic letters (2017) 19, 12 3135-3138
a=9.4297(16)Å b=9.7758(16)Å c=18.503(3)Å
α=90° β=103.717(11)° γ=90°
6-Chloro-1-phenylindolin-2-one
C14H10Cl1N1O1
Acta Crystallographica Section C (2018) 74, 12
a=9.6212(5)Å b=13.4483(7)Å c=19.7967(10)Å
α=72.6810(10)° β=89.9950(10)° γ=69.0510(10)°
6-Chloro-1-phenylindolin-2-one
C14H10ClNO
Acta Crystallographica Section C (2018) 74, 12
a=12.7217(8)Å b=4.8842(3)Å c=19.9554(14)Å
α=90° β=108.5770(10)° γ=90°
4-Chloro-1-phenylindolin-2-one
C14H10ClNO
Acta Crystallographica Section C (2018) 74, 12
a=10.4274(9)Å b=11.8586(10)Å c=9.1689(8)Å
α=90° β=90.341(2)° γ=90°
4-Chloro-1-phenylindolin-2-one
C14H10ClNO
Acta Crystallographica Section C (2018) 74, 12
a=10.5605(8)Å b=12.0485(9)Å c=9.1939(7)Å
α=90° β=89.288(2)° γ=90°
1-(3-Chlorophenyl)-indolin-2-one
C14H10ClNO
Acta Crystallographica Section C (2018) 74, 12
a=11.1067(7)Å b=13.3924(8)Å c=8.0288(5)Å
α=90° β=109.920(2)° γ=90°
1-(3-Chlorophenyl)-indolin-2-one
C14H10ClNO
Acta Crystallographica Section C (2018) 74, 12
a=11.1901(2)Å b=13.6596(3)Å c=8.0965(2)Å
α=90° β=109.9960(10)° γ=90°
1-(2-Bromophenyl)-2-chloro-3-(2-chloracetyl)-1<i>H</i>-indole
C16H10BrCl2NO
Acta Crystallographica Section E (2016) 72, 12 1867-1871
a=10.2155(10)Å b=11.3645(11)Å c=13.5252(13)Å
α=90.00° β=101.141(2)° γ=90.00°
6-Chloro-1-phenylindoline-2,3-dione
C14H8ClNO2
Acta Crystallographica Section E (2017) 73, 6 908-912
a=6.8190(3)Å b=7.7062(3)Å c=21.7492(9)Å
α=90.00° β=90.00° γ=90.00°
O24Si12
O24Si12
Journal of Applied Crystallography (2020) 53, 5 1217-1224
a=20.022(4)Å b=19.899(4)Å c=13.383(3)Å
α=90° β=90° γ=90°
O24Si12
O24Si12
Journal of Applied Crystallography (2020) 53, 5 1217-1224
a=20.022(4)Å b=19.899(4)Å c=13.383(3)Å
α=90° β=90° γ=90°
Mordenite
O96Si48
Journal of Applied Crystallography (2018) 51, 6
a=18.110(4)Å b=20.530(4)Å c=7.5280(15)Å
α=90° β=90° γ=90°
Mordenite
O96Si48
Journal of Applied Crystallography (2018) 51, 6
a=18.110(4)Å b=20.530(4)Å c=7.5280(16)Å
α=90° β=90° γ=90°
<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-Tetrakis(2-methylpropyl)disulfane-1,2-dicarbothioamide
C18H36N2S4
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 11 1764-1769
a=7.2449(11)Å b=9.6102(14)Å c=17.196(3)Å
α=98.580(2)° β=94.540(2)° γ=103.409(2)°
C40H32Cd2N8O12V4
C40H32Cd2N8O12V4
Acta Crystallographica Section E (2004) 60, 8 m1100-m1102
a=16.287(7)Å b=17.201(9)Å c=34.070(16)Å
α=90.00° β=90.00° γ=90.00°
2-(2,4-Dichlorophenyl)-5-methyl-4-(2-nitrophenylsulfonyl)-2H-1,2,4- triazol-3(4H)-one
C15H10Cl2N4O5S
Acta Crystallographica Section E (2006) 62, 3 o935-o937
a=8.192(2)Å b=12.648(3)Å c=16.975(4)Å
α=90.00° β=93.155(4)° γ=90.00°
1-[4-(4-Methylpyrimidin-2-yl)piperazin-1-ylmethyl]-1H-benzotriazole
C16H19N7
Acta Crystallographica Section E (2005) 61, 8 o2602-o2604
a=6.5207(17)Å b=9.2488(16)Å c=13.429(4)Å
α=102.108(8)° β=94.112(7)° γ=101.504(8)°
N-Benzylphthalimide
C15H11NO2
Acta Crystallographica Section E (2006) 62, 7 o2965-o2966
a=7.1840(8)Å b=8.5211(9)Å c=10.2370(11)Å
α=99.062(2)° β=97.578(2)° γ=106.848(2)°
C14H14N4O6S
C14H14N4O6S
Acta Crystallographica Section E (2003) 59, 4 o438-o440
a=7.129(2)Å b=7.529(2)Å c=16.371(5)Å
α=94.350(5)° β=101.426(5)° γ=100.753(5)°
C25H31N3O6
C25H31N3O6
Acta Crystallographica Section C (1993) 49, 9 1568-1571
a=12.577(2)Å b=12.577(2)Å c=29.893(4)Å
α=90° β=90° γ=90°
Diisopropyl 3-methyl-5-oxocyclohex-3-ene-1,1-dicarboxylate
C15H22O5
Acta Crystallographica Section E (2007) 63, 8 o3535-o3535
a=12.302(3)Å b=8.909(3)Å c=14.409(6)Å
α=90.0000° β=96.859(14)° γ=90.0000°
Bis{2,2-[ethane-1,2-diylbis(iminomethylene)]diphenolato- κ^4^O,N,N',O'}cerium(IV) chloroform solvate
C32H36CeN4O4,CHCl3
Acta Crystallographica Section E (2007) 63, 11 m2777-m2778
a=12.4930(10)Å b=14.199(2)Å c=20.253(2)Å
α=90.00° β=104.263(2)° γ=90.00°
(R,S)-Diethyl {[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-ylamino](phenyl)methyl}phosphonate
C19H20Cl2N3O3PS
Acta Crystallographica Section E (2007) 63, 12 o4648-o4648
a=8.4870(17)Å b=16.530(3)Å c=15.703(3)Å
α=90.00° β=94.47(3)° γ=90.00°
2-(2,4-Dichlorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-1,3- thiazolidin-4-one
C18H13Cl2N3O2S2
Acta Crystallographica Section E (2008) 64, 5 o795
a=7.1310(14)Å b=8.1540(16)Å c=16.671(3)Å
α=93.19(3)° β=96.43(3)° γ=105.89(3)°
Dichloridobis(5-<i>m</i>-tolyl-1,3,4-thiadiazol-2-ylamine-κN^3^)zinc(II)
C18H18Cl2N6S2Zn
Acta Crystallographica Section E (2008) 64, 5 m692-m693
a=10.826(2)Å b=11.233(2)Å c=17.892(4)Å
α=90.00° β=90.10(3)° γ=90.00°
N-[4-(3-Chlorobenzyloxy)phenyl]-4,5-dihydrothiazol-2-amine
C16H15ClN2OS
Acta Crystallographica Section E (2007) 63, 12 o4649-o4649
a=12.134(2)Å b=16.931(3)Å c=7.8643(15)Å
α=90.00° β=106.655(3)° γ=90.00°
(Aminoacetato-κ^2^<i>O</i>,<i>N</i>)bis(quinolin-8-olato- κ^2^<i>O</i>,<i>N</i>)cobalt(III) methanol solvate
C20H16CoN3O4,CH4O
Acta Crystallographica Section E (2008) 64, 6 m795
a=9.8377(4)Å b=10.6526(4)Å c=10.7369(4)Å
α=82.0470(10)° β=76.2890(10)° γ=64.9410(10)°
3-[5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-(4-methoxyphenyl)- 1,3-thiazolidin-4-one
C18H14FN3O2S2
Acta Crystallographica Section E (2008) 64, 7 o1359
a=6.4550(13)Å b=8.9200(18)Å c=16.483(3)Å
α=75.78(3)° β=82.44(3)° γ=71.11(3)°
2-Methoxy-<i>N</i>-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]benzamide hemihydrate
C17H15N3O3S,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 8 o1637
a=29.950(6)Å b=14.561(3)Å c=7.6520(15)Å
α=90.00° β=94.78(3)° γ=90.00°
(<i>S</i>)-2-(Pyrrolidinium-2-ylmethyl)isoquinolinium dibromide
C14H18N2,2Br
Acta Crystallographica Section E (2007) 63, 6 o2786-o2786
a=6.1326(6)Å b=7.3174(7)Å c=9.8781(10)Å
α=93.817(2)° β=104.335(2)° γ=114.4080(10)°
2-(2,4-Dichlorophenyl)-3-[5-(3,5-dimethylphenyl)-1,3,4-thiadiazol-2- yl]thiazolidin-4-one
C19H15Cl2N3OS2
Acta Crystallographica Section E (2008) 64, 1 o260-o260
a=8.1760(16)Å b=9.1650(18)Å c=14.483(3)Å
α=80.60(3)° β=80.82(3)° γ=63.92(3)°
Ethyl 2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy]propanoate
C14H16N2O4
Acta Crystallographica Section E (2007) 63, 6 o2897-o2897
a=15.7947(15)Å b=7.8792(5)Å c=10.8786(12)Å
α=90.00° β=91.190(9)° γ=90.00°
<i>N</i>-{(<i>E</i>)-4-[(<i>E</i>)-(Dodecylimino)methyl]benzylidene}dodecan-\ 1-imine ?
C32H56N2
Acta Crystallographica Section E (2008) 64, 3 o565
a=4.7370(9)Å b=5.5190(11)Å c=30.315(6)Å
α=91.18(3)° β=93.44(3)° γ=101.75(3)°
Diethyl {(4-methoxyphenyl)[5-(4-nitrophenyl)-1,3,4-thiadiazol-2- ylamino]methyl}phosphonate
C20H23N4O6PS
Acta Crystallographica Section E (2008) 64, 8 o1376
a=11.481(2)Å b=19.426(4)Å c=11.960(2)Å
α=90.00° β=117.08(3)° γ=90.00°
Tert-butyl 2-borono-1<i>H</i>-pyrrole-1-carboxylate
C9H14BNO4
Acta Crystallographica Section E (2009) 65, 4 o687
a=13.014(3)Å b=9.940(2)Å c=17.417(4)Å
α=90.00° β=90.00° γ=90.00°
5-(4-Pyridyl)-1,3,4-thiadiazol-2-amine
C7H6N4S
Acta Crystallographica Section E (2009) 65, 5 o1099
a=14.794(3)Å b=10.686(2)Å c=10.477(2)Å
α=90.00° β=106.52(3)° γ=90.00°
4-(2<i>H</i>-Tetrazol-5-yl)pyridinium hydrogen sulfate
C6H6N5,HO4S
Acta Crystallographica Section E (2009) 65, 10 o2398
a=6.6515(13)Å b=7.5507(15)Å c=10.072(2)Å
α=77.72(3)° β=76.88(3)° γ=79.71(3)°
3-Cyanoanilinium bromide
C7H7N2,Br
Acta Crystallographica Section E (2009) 65, 10 o2396
a=4.6396(9)Å b=6.1757(12)Å c=13.542(3)Å
α=93.07(3)° β=96.22(3)° γ=97.33(3)°
3-Cyanoanilinium nitrate
C7H7N2,NO3
Acta Crystallographica Section E (2009) 65, 10 o2395
a=10.210(2)Å b=10.812(2)Å c=15.398(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>S</i>)-1-Methoxycarbonyl-3-(4-nitrophenyl)propan-2-aminium bromide
C10H13N2O4,Br
Acta Crystallographica Section E (2009) 65, 10 o2397
a=4.9323(10)Å b=8.6233(17)Å c=15.226(3)Å
α=90.00° β=95.77(3)° γ=90.00°
(1<i>R</i>,3<i>S</i>)-Methyl 3-[(<i>S</i>)-2- (hydroxydiphenylmethyl)pyrrolidin-1-ylmethyl]-2,2- dimethylcyclopropanecarboxylate
C25H31NO3
Acta Crystallographica Section E (2009) 65, 10 o2474
a=34.736(7)Å b=17.729(4)Å c=11.013(2)Å
α=90.00° β=97.62(3)° γ=90.00°
Diaquadichlorido[5-(3-pyridinio)tetrazolato-κ<i>N</i>^2^]copper(II) dihydrate
C12H14Cl2CuN10O2,2H2O
Acta Crystallographica Section E (2009) 65, 10 m1188
a=6.5484(13)Å b=8.3348(17)Å c=9.1215(18)Å
α=99.54(3)° β=110.22(3)° γ=91.73(3)°
5-Chloropyrimidin-2-amine
C4H4ClN3
Acta Crystallographica Section E (2009) 65, 11 o2863
a=7.6380(15)Å b=8.2240(16)Å c=17.100(3)Å
α=90.00° β=90.00° γ=90.00°
Bis{6-[4-(2-ethyoxyphenyldiazenyl)phenoxy]hexanol} monohydrate
2(C20H26N2O3),H2O
Acta Crystallographica Section E (2009) 65, 3 o509
a=7.4586(7)Å b=11.5674(11)Å c=24.070(2)Å
α=90.46(3)° β=98.46(3)° γ=106.10(3)°
Triaquadichlorido[5-(4-pyridinio)tetrazolato-κ<i>N</i>^2^]cobalt(II) monohydrate
C6H11Cl2CoN5O3,H2O
Acta Crystallographica Section E (2009) 65, 8 m853
a=6.4900(13)Å b=9.842(2)Å c=11.159(2)Å
α=110.72(3)° β=97.05(3)° γ=106.27(3)°
<i>N</i>-(4-Hydroxyphenethyl)acetamide
C10H13NO2
Acta Crystallographica Section E (2009) 65, 8 o1789
a=9.9206(13)Å b=8.7861(11)Å c=11.4943(16)Å
α=90.00° β=102.9980(10)° γ=90.00°
Aquachloridobis[5-(2-pyridyl)-1<i>H</i>-tetrazolato-κ<i>N</i>^1^]iron(III)
C12H10ClFeN10O
Acta Crystallographica Section E (2009) 65, 8 m861
a=17.072(3)Å b=7.1905(14)Å c=14.292(3)Å
α=90.00° β=113.85(3)° γ=90.00°
Methyl 5-chloro-2-(4-methylbenzenesulfonamido)benzoate
C15H14ClNO4S
Acta Crystallographica Section E (2010) 66, 6 o1462
a=18.549(4)Å b=9.935(2)Å c=8.5190(17)Å
α=90.00° β=97.34(3)° γ=90.00°
(Ferrocenylmethyl)dimethylammonium bromide
C13H18FeN,Br
Acta Crystallographica Section E (2010) 66, 6 m686
a=21.393(4)Å b=5.9296(12)Å c=10.798(2)Å
α=90.00° β=90.00° γ=90.00°
4-(<i>N</i>-Propan-2-ylcarbamoyl)pyridinium perchlorate
C9H13N2O,ClO4
Acta Crystallographica Section E (2010) 66, 6 o1473
a=4.9342(3)Å b=8.973(4)Å c=13.715(10)Å
α=93.046(12)° β=91.07(2)° γ=101.01(3)°
Diaquadibromidocopper(II)--18-crown-6--water (1/1/2)
C12H24O6,Br2CuH4O2,2(H2O)
Acta Crystallographica Section E (2010) 66, 7 m836
a=7.4418(5)Å b=8.1724(6)Å c=10.1510(2)Å
α=75.220(3)° β=69.470(10)° γ=78.510(10)°
8-Nitroquinoline
C9H6N2O2
Acta Crystallographica Section E (2011) 67, 4 o957
a=7.2421(11)Å b=16.688(3)Å c=7.2089(11)Å
α=90.00° β=114.086(4)° γ=90.00°
Adamantan-1-aminium <i>p</i>-toluenesulfonate
C10H18N,C7H7O3S
Acta Crystallographica Section E (2011) 67, 3 o543
a=6.464(2)Å b=11.589(4)Å c=22.562(8)Å
α=92.975(4)° β=94.034(5)° γ=96.408(5)°
1,4-Diazoniabicyclo[2.2.2]octane tetrabromidocuprate(II) monohydrate
C6H14N22,Br4Cu2,H2O
Acta Crystallographica Section E (2011) 67, 3 m371
a=9.5171(19)Å b=9.5341(19)Å c=14.952(3)Å
α=90.00° β=93.93(3)° γ=90.00°
(<i>S</i>)-1-Carboxy-2-(4-nitrophenyl)ethanaminium bromide
C9H11N2O4,Br
Acta Crystallographica Section E (2009) 65, 10 o2420
a=5.5378(11)Å b=7.4158(15)Å c=14.246(3)Å
α=90.00° β=91.15(3)° γ=90.00°
Methyl 4-(3-chloropropoxy)-3-methoxybenzoate
C12H15ClO4
Acta Crystallographica Section E (2009) 65, 2 o231
a=8.4980(17)Å b=17.349(4)Å c=8.8440(18)Å
α=90.00° β=106.46(3)° γ=90.00°
C18H18N4O2
C18H18N4O2
Acta Crystallographica Section E (2009) 65, 2 o344
a=20.113(4)Å b=10.590(2)Å c=7.6820(15)Å
α=90.00° β=94.78(3)° γ=90.00°
Diaquabis{2-[5-(2-pyridyl)-2<i>H</i>-tetrazol-2-yl]acetato- κ^2^<i>N</i>^4^,<i>N</i>^5^}zinc(II)
C16H16N10O6Zn
Acta Crystallographica Section E (2009) 65, 7 m831
a=7.6407(15)Å b=8.2583(17)Å c=15.155(3)Å
α=90.00° β=97.17(3)° γ=90.00°
Dichloridobis(5-heptyl-1,3,4-thiadiazol-2-amine-κ<i>N</i>^3^)zinc(II)
C18H34Cl2N6S2Zn
Acta Crystallographica Section E (2009) 65, 9 m1086
a=8.1750(16)Å b=11.663(2)Å c=14.666(3)Å
α=73.150(17)° β=77.83(2)° γ=88.81(3)°
4-(2-methylpiperidine-1-carbonyl)pyridinium hexachloridoantimonate(V)
C12H17N2O,Cl6Sb
Acta Crystallographica Section E (2009) 65, 10 m1219
a=8.1067(16)Å b=12.700(3)Å c=19.677(4)Å
α=90.00° β=99.06(3)° γ=90.00°
Adamantane-1-ammonium benzoate
C10H18N,C7H5O2
Acta Crystallographica Section E (2009) 65, 11 o2769
a=10.918(2)Å b=6.5664(13)Å c=21.197(4)Å
α=90.00° β=100.07(3)° γ=90.00°
5-(4-Chlorophenyl)-1<i>H</i>-tetrazole
C7H5ClN4
Acta Crystallographica Section E (2010) 66, 4 o742
a=9.4596(19)Å b=11.437(2)Å c=7.2988(15)Å
α=90.00° β=107.91(3)° γ=90.00°
Methyl 5-chloro-2-[<i>N</i>-(3-ethoxycarbonylpropyl)- 4-methylbenzenesulfonamido]benzoate
C21H24ClNO6S
Acta Crystallographica Section E (2010) 66, 7 o1819
a=9.1480(18)Å b=10.742(2)Å c=23.258(5)Å
α=90.00° β=90.00° γ=90.00°
{2-[2-(Carboxymethoxy)phenoxy]acetato}[2,2'-(<i>o</i>-phenylenedioxy)diacetic acid]sodium 4,4'-bipyridine hemisolvate monohydrate
C20H19NaO12,0.5(C10H8N2),H2O
Acta Crystallographica Section E (2010) 66, 8 m867
a=8.427(4)Å b=13.135(7)Å c=13.411(9)Å
α=111.08(2)° β=102.03(2)° γ=103.17(2)°
<i>catena</i>-Poly[[dichloridomercury(II)]-μ-1,4-bis[2-(pyridin-4-yl)ethynyl]benzene-κ^2^<i>N</i>:<i>N</i>]
C20H12Cl2HgN2
Acta Crystallographica Section E (2014) 70, 6 m208
a=12.285(3)Å b=4.8482(10)Å c=15.271(3)Å
α=90.00° β=98.00(3)° γ=90.00°
(<i>Z</i>)-2-(4-<i>tert</i>-Butylphenyl)-1-(4-chloro-1-ethyl-3-methyl- 1<i>H</i>-pyrazol-5-yl)-2-cyanovinyl pivalate
C24H30ClN3O2
Acta Crystallographica Section E (2011) 67, 8 o2027
a=10.1796(7)Å b=10.5648(7)Å c=12.3632(8)Å
α=90.00° β=110.6130(10)° γ=90.00°